Cancer Letters

Cancer Letters

Volume 283, Issue 1, 28 September 2009, Pages 84-91
Cancer Letters

Identification of liver metastasis-related genes in a novel human pancreatic carcinoma cell model by microarray analysis

https://doi.org/10.1016/j.canlet.2009.03.030Get rights and content

Abstract

Pancreatic cancer with liver metastases has a poor prognosis and the molecular mechanisms remain unclear. In this study, SW1990HM, a highly metastatic human pancreatic carcinoma line was subcloned from SW1990 by intrasplenic injection. In vivo and in vitro tumorigenicity, metastatic potential, in vitro invasion, cell growth curves, plate efficiency and S-phase cell numbers were higher in SW1990HM cells. Gene expression profiles of SW1990HM and SW1990 cells showed 40 metastasis-related genes expressed with a 3-fold difference. Thirteen of these 32.5% (13/40) were adhesion and extracellular-matrix related and twelve 30% (12/40) were cell growth and proliferation related, such as MMP10, MMP9, MMP7, CDH1, MGAT5, CTNNA1, IGF1, IL8RB, ITGA7, MDM2, MET, SSTR2 and VEGF, which were related to the onset and progression of tumor metastasis. Thus, SW1990HM is an attractive model to study metastasis and identify potential therapeutic targets.

Introduction

Pancreatic cancer is a lethal disease characterized by early metastasis, local invasion, and resistance to conventional therapies [1]. Given the absence of early symptoms and extremely poor prognosis, it becomes imperative to understand the mechanism of disease onset, progression and metastasis in order to arrive at new treatment strategies. Dissecting the cellular and molecular biology of pancreatic cancer metastasis and generating biologically and clinically relevant model systems will not only lead to a better understanding of the disease, but also elucidate environmental and genetic effects on pancreatic metastasis.

Several mouse models have recently been used to select metastatic cell subpopulations in human pancreatic cancer. Highly liver metastatic variants were established by intrasplenic injection of cancer cells and by orthotopic implantation of cancer tissues [2], [3], [4], [5]. The selection of the optimal model for each biological or translation question is very important, since individual model systems provide limited information. Screening and establishing a human pancreatic carcinoma cell line that is highly metastatic to the liver would provide a useful tool to study the mechanism of liver metastasis in pancreatic cancer. Gene expression analysis in this setting would generate new markers for therapeutic purposes. We recently isolated human pancreatic carcinoma clones with highly liver metastatic potential from SW1990, a human pancreatic cancer cell line [6]. Animal models of this cell line also have been developed and characterized by Authors’ Institute.

We compared the established cell line (SW1990) to our newly developed metastatic cell line (SW1990HM) to evaluate differences in the expression of several genes known to be important in cancer metastasis and identify molecular and cellular pathways that could be key in determining the onset of metastasis. In order to achieve this, we carried out gene expression profiling of the parental and the metastatic variant using the Tumor Metastasis PCR Array.

The Human Tumor Metastasis RT2 Profiler™ PCR Array is designed to represent 84 genes known to be involved in metastasis. Genes selected for this array encode several classes of proteins, including cell adhesion, ECM components, cell cycle, cell growth and proliferation, apoptosis as well as transcription factors and regulators. This array helps investigate the molecular mechanism of metastasis. Coupled with real-time PCR, it provides a reliable tool to analyze the expression of a focused panel of metastasis-related genes.

In this study, we demonstrate that our new liver metastasis cell line, SW1990HM is a useful tool to study the molecular mechanism of metastasis and develop therapeutic modalities for pancreatic cancer patients with liver metastases.

Section snippets

Cell line and animals

The SW1990 human pancreatic carcinoma line was established from a spleen metastasis acquired in 1978 from a patient with grade II pancreatic cancer. The procedure used to establish SW1990 has been previously described [6]. The cell line was cultured in Leibovitz’s L-15 medium supplemented with 10% fetal bovine serum (FBS), 2 ml glutamine, 50 U/ml penicillin, and 50 mg/ml streptomycin in a humidified atmosphere of 95% air and 5% CO2 at 37 °C. The cells were expanded via trypsinization of cell

Selection of a highly metastatic variant line

After six consecutive rounds of in vivo liver metastasis selection, the liver metastases were obvious and metastatic lesions were harvested to establish a tumor cell line (Fig. 1). This was designated SW1990HM and was cultured in Leibovitz’s L-15 medium supplemented with 10% (v/v) fetal bovine serum at 37 °C in 5% CO2/95% air.

Metastatic ability and tumorigenicity

The characteristics of each cell line established in a stepwise fashion are summarized in Table 1. Liver metastasis was observed within 6 weeks after intrasplenic

Discussion

In this study, we describe the isolation and establishment of a highly liver metastatic cell line, SW1990HM from the parental cell line SW1990. We found that SW1990HM cells exhibited significantly greater metastatic activity after intrasplenic injection when compared to the parent cells. It is noteworthy that SW1990HM cells exhibited a higher degree of metastatic activity to liver, where metastases are most frequently detected in patients with pancreatic cancer.

The SW1990HM and parental SW1990

Conflicts of interest

None declared.

Acknowledgements

The authors thank Professor Zhimin Shao, Ph.D., MD, Chair of Breast Surgery; Yifeng Hou, Ph.D., MD; Jianming Luo, Department of Breast Surgery, of the Breast Cancer Institute, Fudan University, for their help with this work. We also thank Lixin Chen for his help with the animal experiments.

References (40)

  • I.J. Fidler

    Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis

    Cancer Metast. Rev.

    (1986)
  • R. Giavazzi et al.

    Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice

    Cancer Res.

    (1986)
  • A. Albini et al.

    RNA rapid in vitro assay for quantitating the invasive potential of tumor cells

    Cancer Res.

    (1987)
  • D. Fan et al.

    Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine–phosphatidylserine liposomes

    Cancer Res.

    (1990)
  • Y. Liao et al.

    Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20

    Hepato-Gastroenterology

    (2000)
  • R. Denno et al.

    Tumorigenicity motility and liver metastasis of human gastric carcinoma lines with high metastatic potential in the liver of the nude mice

    Tumor Res.

    (1996)
  • Y. Sakurai et al.

    Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis

    Clin. Exp. Metast.

    (1997)
  • K. Morikawa et al.

    In vivo selection of highly metastatic cells from surgical specimens of different primary human colorectal carcinomas implanted into nude mice

    Cancer Res.

    (1988)
  • Yan Li et al.

    Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97

    World J. Gastroenterol.

    (2001)
  • D. Wei et al.

    Experimental animal models of pancreatic carcinogenesis and metastasis

    Int. J. Gastrointest. Cancer

    (2003)
  • Cited by (0)

    View full text